Insulin-induced activation of hypoxia-inducible factor-1 requires generation of reactive oxygen species by NADPH oxidase. Am J Physiol Heart Circ Physiol 292: H758 -H766, 2007. First published November 3, 2006; doi:10.1152/ajpheart.00718.2006.-Hypoxia-inducible factor (HIF)-1 activation in response to hypoxia requires mitochondrial generation of reactive oxygen species (ROS). In contrast, the requirement of ROS for HIF-1 activation by growth factors like insulin remains unexplored. To explore that, insulin-sensitive hepatic cell HepG2 or cardiac muscle cell H9c2 cells were pretreated with NADPH oxidase inhibitor diphenyleneiodonium chloride (DPI) or apocynin and HIF-1 activation was tested by electrophoretic mobility shift and reporter gene assay. Antioxidants DPI or apocynin completely blocked insulin-stimulated HIF-1 activation. The restoration of HIF-1 activation by H2O2 in DPI-pretreated cells not only confirmed the role of ROS but also identified H2O2 as the responsible ROS. The role of NADPH oxidase was further confirmed by greater stimulation of HIF-1 during simultaneous treatment of suboptimal concentration of insulin along with NADPH but not by NADH. The role of oxidant generated by insulin is found to inhibit the protein tyrosine phosphatase as suggested by the following observations. First, tyrosine phosphatase-specific inhibitor sodium vanadate compensates DPI-inhibited HIF-1 activity. Second, sodium vanadate stimulates HIF-1 activation with suboptimal concentration of insulin. Third, DPI and pyrrolidene dithiocarbamate (PDTC) blocks insulin-receptor tyrosine kinase activation. The activity of phosphatidylinositol 3-kinase as evidenced by Akt phosphorylation, involved in HIF-1 activation, is also dependent on ROS generation by insulin. Finally, DPI pretreatment blocked insulin-stimulated expression of genes like VEGF, GLUT1, and ceruloplasmin. Overall, our data provide strong evidence for the essential role of NADPH oxidase-generated ROS in insulinstimulated activation of HIF-1. reduced nicotinamide adenine dinucleotide phosphate oxidase; gene expression REACTIVE OXYGEN SPECIES (ROS) are originally thought to have only deleterious biological effects on organisms by virtue of their potential to cause oxidative damages to cellular components. However, it has been appreciated later that ROS play a very significant role in normal biological processes, including signaling pathways regulating various transcription factors like activator protein-1 (18, 19), NF-B (4, 19), p53 (22), and subsequent gene expression. In the growing list of transcription factors influenced by cellular ROS generation, a recent addition is the hypoxia-induced oxygen sensing transcription factor hypoxia-inducible factor (HIF)-1. The HIF-1 is found to be consisting of a dimer of subunits HIF-1␣ and HIF-1␤. In normoxia, the hydroxylation of HIF-1␣ at the proline residues (402 and 564) is catalyzed by proline hydroxylases using molecular oxygen as the substrate (13-15). The tumor suppressor von Hippel-Lindau protein specifically binds with hydroxylated HIF-1␣ and promotes subsequent ubiquitinization and proteolysis (27), whereas HIF-1␤ is found to be constitutive. In response to hypoxia, HIF-1␣ is not hydroxylated at the proline residues and therefore is stabilized. The stabilized HIF-1␣ translocates into the nucleus and binds to HIF-1␤ and thus forms HIF-1 complex and binds to hypoxia response element (HRE, 5Ј-RCGTG-3Ј) to increase the transcription of target genes like VEGF, GLUT1, erythropoietin (Epo), and others (13). For the last several years there have been contradictory reports on the participation of mitochondria-generated ROS in hypoxia-induced activation of HIF-1 (17). Initially, it was reported that mitochondria produced a burst of ROS in response to hypoxia and that this burst is necessary and sufficient to activate HIF-1 (6). The involvement of ROS, as well as any conventional signaling pathways, was the subject of concern because of the observation that, during hypoxia, decline in oxygen levels directly decreases the activity of the prolyl hydroxylases, thereby preventing hydroxylation of the HIF-1␣ protein (7). A series of articles published recently, however, reconfirms the participation of mitochondrial ROS in HIF-1 activation by hypoxia (5, 11, 26) using a p38 MAP kinase pathway (7), although exactly how ROS activates HIF-1 still remains to be understood.
REACTIVE OXYGEN SPECIES (ROS) are originally thought to have only deleterious biological effects on organisms by virtue of their potential to cause oxidative damages to cellular components. However, it has been appreciated later that ROS play a very significant role in normal biological processes, including signaling pathways regulating various transcription factors like activator protein-1 (18, 19) , NF-B (4, 19) , p53 (22) , and subsequent gene expression. In the growing list of transcription factors influenced by cellular ROS generation, a recent addition is the hypoxia-induced oxygen sensing transcription factor hypoxia-inducible factor (HIF)-1. The HIF-1 is found to be consisting of a dimer of subunits HIF-1␣ and HIF-1␤. In normoxia, the hydroxylation of HIF-1␣ at the proline residues (402 and 564) is catalyzed by proline hydroxylases using molecular oxygen as the substrate (13) (14) (15) . The tumor suppressor von Hippel-Lindau protein specifically binds with hydroxylated HIF-1␣ and promotes subsequent ubiquitinization and proteolysis (27) , whereas HIF-1␤ is found to be constitutive. In response to hypoxia, HIF-1␣ is not hydroxylated at the proline residues and therefore is stabilized. The stabilized HIF-1␣ translocates into the nucleus and binds to HIF-1␤ and thus forms HIF-1 complex and binds to hypoxia response element (HRE, 5Ј-RCGTG-3Ј) to increase the transcription of target genes like VEGF, GLUT1, erythropoietin (Epo), and others (13) . For the last several years there have been contradictory reports on the participation of mitochondria-generated ROS in hypoxia-induced activation of HIF-1 (17) . Initially, it was reported that mitochondria produced a burst of ROS in response to hypoxia and that this burst is necessary and sufficient to activate HIF-1 (6) . The involvement of ROS, as well as any conventional signaling pathways, was the subject of concern because of the observation that, during hypoxia, decline in oxygen levels directly decreases the activity of the prolyl hydroxylases, thereby preventing hydroxylation of the HIF-1␣ protein (7) . A series of articles published recently, however, reconfirms the participation of mitochondrial ROS in HIF-1 activation by hypoxia (5, 11, 26 ) using a p38 MAP kinase pathway (7) , although exactly how ROS activates HIF-1 still remains to be understood.
Besides hypoxia, HIF-1 is also activated in normoxic conditions by several important physiological stimuli like insulin (35, 38) , IGF-I/II (38) , EGF (30) , PDGF, and angiotensin II (31) . Incidentally, insulin is known to increase the intracellular ROS generation to regulate the posttranslational translocation of GLUT4 (23, 24) . Insulin plays a crucial role in regulating the metabolic pathways associated with energy storage and utilization. It regulates expression of GLUT1 and phosphoglycerate kinase-1 and several other genes like VEGF, Epo, and endothelin-1 (13) . Insulin increases the transcription of many of these target genes by activating HIF-1 (38) . We also have demonstrated that insulin regulates iron homeostasis gene ceruloplasmin (Cp) by activating HIF-1 (35) . The current study is aimed to investigate the role of insulin-induced ROS generation in HIF-1 activation and subsequent gene expression. Here we demonstrated that insulin-stimulated ROS generation by NADPH oxidase is essential for the activation of HIF-1 in insulin-sensitive hepatic cells HepG2 and cardiac myoblasts H9c2. To understand the mechanism, we found that, in HepG2 cells, the NADPH oxidase-generated ROS regulates phosphorylation of insulin receptor kinases as well as phosphatidylinositol 3-kinase (PI3-kinase) activity, essential for HIF-1 activation and subsequent expression of genes like VEGF, GLUT1, and Cp.
MATERIALS AND METHODS
Reagents. Human recombinant insulin (Invitrogen), apocynin, diphenyleneiodonium chloride (DPI), 2Ј,7Ј-dichlorodihydrofluorescein (DCF) diacetate (DCF-DA) were purchased from (Calbiochem). Monoclonal anti-phosphotyrosine (4G10) and polyclonal antibodies to the insulin receptor ␤-subunit (IR-␤), insulin receptor substrate-1 (IRS-1), were from Upstate Biotechnology. Antibodies to phosphorylated Akt (Ser473) and Akt protein (not isoform specific) were purchased from New England Biolabs. All cell culture reagents and other reagents were obtained from Sigma, unless otherwise mentioned.
Cell lines and culture conditions. Human hepatocarcinoma HepG2 cells and cardiac myoblasts H9c2 cells (from ATCC) were cultured in DMEM, supplemented with 10% heat-inactivated fetal bovine serum (Invitrogen), 100 U/ml penicillin, 100 mg/ml streptomycin, and 2 mM L-glutamine. Cells at 50 -60% confluence were used in all experiments and were treated with appropriate concentrations of insulin after serum deprivation. Cells were maintained in a humidified atmosphere containing 5% CO 2-95% air at 37°C (Forma-Scientific).
Intracellular ROS measurement in cell culture. Fluoresence microscopy and spectrophotometry were used to measure intracellular ROS with DCF-DA as the probe. Cells incubated with medium alone or cells treated with various compounds to induce ROS production as mentioned in respective experiments were incubated with 5 M DCF-DA in DMEM for 30 min at 37°C in the dark. The cells were washed in PBS, trypsinized, and resuspended in 3 ml PBS, and the intensity of fluorescence was immediately read in a fluorescence spectrophotometer at 500 nm for excitation and at 530 nm for emission (6) . Similarly, ROS production was also checked by fluorescence microscopy using the probe DCF-DA.
Immunoblot analysis. After the treatment, as indicated in different experiments, cells were lysed in buffer containing 50 mM HEPES (pH 7.5), 150 mM NaCl, 1% Triton X-100, 100 mM sodium fluoride, 1 mM EGTA, 1 mM EDTA, 2 mM sodium vanadate (NaV), 10 mM sodium pyrophosphate, 1 mM phenylmethylsulfonyl fluoride, and a protease inhibitor mixture (Roche Applied Science). The lysates were briefly sonicated and centrifuged at 13,000 g for 10 min; 40 g of protein of the cleared supernatant were resolved by SDS-polyacrylamide gel electrophoresis and transferred to polyvinylidene difluoride (PVDF) membrane. PVDF membranes were subjected to immunoblotting with either monoclonal antibody for phosphotyrosine (4G10) to detect IR-␤ and IRS tyrosine phosphorylation; polyclonal antibody to detect phospho-Akt; or additional antibodies to detect total protein levels of the IR-␤, IRS-1, and Akt, where indicated. After incubation with horseradish peroxidase-conjugated secondary antibodies, proteins were visualized by enhanced chemiluminescence, according to the manufacturer's protocol (Amersham Biosciences).
RNA blot analysis. RNA was isolated from serum-deprived HepG2 cells using Tripure reagent (Roche Applied Science). Total RNA (20 g) was denatured in formamide/formaldehyde, electrophoresed through 1% agarose gel containing 6% formaldehyde, and then blotted onto nylon membranes (Schleicher and Schuell). After being crosslinked by ultraviolet irradiation (Stratalinker, Stratagene), the membranes were hybridized to a 0.65-kb EcoRI fragment of VEGF 165 (35) , 646-base pair (bp) BstXI/BamHI restriction fragment (positions 984 -1,629 of the open reading frame) of a human Cp cDNA as described (35) , or 0.6 kb-fragment of GLUT1 (generated by RT-PCR, cloned into pcDNA3 and confirmed by sequencing) as described before (38) and labeled by random priming with [␣-32 P]dCTP using a New England Biolab kit.
Preparation of nuclear extracts. Nuclear extracts were prepared from HepG2 cells as described before (35) . Briefly, 1 ϫ 10 8 cells were washed with ice-cold phosphate-buffered saline and then with a solution containing (in mM) 10 Tris ⅐ HCl (pH 7.8), 1.5 MgCl2, and 10 KCl, supplemented with a protease inhibitor mixture containing 0.5 DTT and 0.4 phenylmethylsulfonyl fluoride and 2 g/ml each of leupeptin, pepstatin, and aprotinin. After incubation on ice for 10 min, the cells were lysed by 10 strokes with a Dounce homogenizer, and the nuclei were pelleted. The pellet was resuspended in a solution containing (in mM) 420 KCl, 20 Tris ⅐ HCl (pH 7.8), and 1.5 MgCl2 and 20% glycerol, supplemented with the protease mixture described above and incubated at 4°C with gentle agitation. The nuclear extract was centrifuged at 10,000 g for 10 min, and the supernatant was dialyzed twice against a solution containing (in mM) 20 Tris ⅐ HCl (pH 7.8), 100 KCl, and 0.2 EDTA and 20% glycerol. Protein concentration was determined by using the Bio-Rad reagent with bovine serum albumin as standard.
Electrophoretic mobility shift assay. Sequences of the sense strands of the oligonucleotide probes used for EMSA were as follows: 5Ј-TCT GTA CGT GAC CAC ACT CAC CTC-3Ј (Cp-HRE) and 5Ј-GCC CTA CGT GCT GTC TCA CAC AGC-3Ј (Epo-HRE). The sense and antisense strands were annealed, gel purified, and endlabeled with [␥ 32 P]ATP using T4-polynucleotide kinase (Promega). Unincorporated nucleotide was removed by gel filtration using G-25 Sephadex columns (Quick Spin TE, Roche Applied Science). To measure DNA protein interaction, 1 ϫ 10 5 counts/min of oligonucleotide probe were incubated with 5 g of nuclear extract and 0.5 g of sonicated, denatured salmon sperm DNA (Invitrogen) in 10 mM Tris ⅐ HCl (pH 7.8), 50 mM NaCl, 1 mM MgCl 2, 1 mM EDTA, 5 mM DTT, and 5% glycerol for 20 min at 4°C in a total volume of 20 l. The reaction mixture was subjected to electrophoresis (200 V in 0.3ϫ Tris-buffered EDTA solution at 4°C) using 5% nondenaturing polyacrylamide gels. Dried gels were subjected to autoradiography for up to 24 h.
Construction of vectors containing Cp-HRE.
Cp promoter/enhancer construct containing hypoxia response element (Cp-HRE) between Ϫ3,639 and Ϫ3,544 nt from Cp translation initiation site was ligated into the SacI and XhoI sites of the pGL3prom vector (Promega) upstream of the SV40 promoter and luciferase gene as described before (28, 35) . Site-directed mutagenesis of the Cp-HRE in this construct (from TACGTG to TAAAAG) was done by megaprimer method (28, 35) . All constructs were verified by sequencing.
Transient transfection of cells and reporter gene assays. To measure transcriptional efficiency of chimeric Cp-HRE construct, HepG2 or H9c2 cells at ϳ50% confluence in 35-mm dishes were transiently transfected for 6 h with a reporter plasmid (2 g) using Lipofectamin 2000 (Invitrogen). To monitor transfection efficiency, a reporter gene construct (0.25 g) containing ␤-galactosidase behind an SV40 promoter was cotransfected as described earlier. Transfected cells were allowed to recover for 6 h in DMEM with 10% fetal bovine serum and, after serum deprivation, were incubated with insulin or other treatments in serum-free medium for 16 h as described elsewhere (35) . Luciferase (Promega) and ␤-galactosidase (Invitrogen) activities in cell extracts were determined as described in the manufacturer's protocol.
Statistical analysis. All experiments have been performed at least three times with similar results, and representative experiments are shown. Results from estimation of ROS and reporter experiments are expressed as means Ϯ SE (n ϭ 3 individual experiments).
RESULTS

Insulin-stimulated ROS regulates HIF-1 activation.
To check that insulin induces ROS in HepG2 cell and characterize it, serum-deprived cells were incubated with DCF-DA, a sensitive oxidant indicator dye. Following stimulation with different concentrations of insulin, DCF fluorescence was estimated after 10 min. Figure 1A shows that insulin treatment increased ROS generation compared with untreated cells by a concentration-dependent manner, and maximum increase of ϳ100% was found by 10 nM insulin. The generation of ROS was optimal at ϳ10 min, and, after 30 min of stimulation, the fluorescence by ROS generation was almost undetectable (data not shown). Pretreatment of the cells with 5 M DPI or apocynin (300 M), inhibitors of NADPH oxidase before insulin treatment, completely blocked the increase in DCF fluorescence, indicating the involvement of NADPH oxidase in ROS generation by insulin (Fig. 1B) . A similar result was also found by the pretreatment of antioxidant PDTC, whereas a specific scavenger of superoxide radical SOD failed to show any effect, indicating that either superoxide is not involved in the process or the addition of SOD from outside the cell could not block intracellular ROS generation. Similar effects of DPI and apocynin were also obtained by fluorescence microscopy (Fig. 1C) . Cardiac myoblasts H9c2 also showed similar results in response to insulin, although induction of ROS was found faster than in HepG2 cells (data not shown).
We have previously shown that insulin activates HIF-1 to increase Cp expression by interacting with Cp-HRE (35) . To find the optimal concentration of insulin to activate HIF-1, we transfected Cp-HRE-driven luciferase chimera in to HepG2 cells and treated with increasing concentration of insulin. A maximum induction of ϳ3.3-fold luciferase activity was detected by 10 nM of insulin, whereas mutated HRE failed to show any considerable induction ( Fig. 2A) . To find out whether insulin-stimulated ROS generation is involved in HIF-1 activation, HepG2 cells were pretreated with DPI (5 M) or apocynin (300 M) before insulin treatment (10 nM) and, after 8 h, nuclear extracts were prepared for EMSA. Insulin-induced DNA binding complex of HIF-1 was completely blocked either by DPI or apocynin pretreatment (Fig. 2B) . The identity of the HIF-1-DNA complex was confirmed by supershift analysis using HIF-1␣ antibody (Fig. 2C) . Similarly, when serumdeprived H9c2 cells were pretreated with antioxidant PDTC (100 M), insulin-stimulated Epo-HRE-HIF-1 complex formation was also completely blocked (Fig. 2D) . The involvement of ROS in insulin-stimulated HIF-1 activation was further confirmed by HRE-driven reporter luciferase assay. Pretreatment of antioxidants, like DPI, apocynin, or PDTC, were found to block insulin-stimulated ROS generation and to completely block the insulin-dependent increase in luciferase reporter activity in HepG2 (Fig. 2E ) and H9c2 (data not shown) cells. The SOD, which failed to block insulin-dependent ROS gen- HepG2 cells were treated with diphenyleneiodonium chloride (DPI; 5 M), apocynin (300 M), pyrrolidine dithiocarbamate (PDTC; 100 M), and SOD (100 U/ml) for 30 min before Ins (10 nM) treatment, and, after 10 min, DCF fluorescence was measured. Experiments were repeated at least 3 times. Results are expressed as means Ϯ SE (n ϭ 3 replicate wells). C: HepG2 cells were plated onto a glass slip on a 12-well plate and, after 24 h, changed to the serumfree condition, followed by 1 h of DPI and apocynin treatment. DCF-DA (10 M) was added 30 min before the Ins treatment (10 nM). After 10 min, cells were washed twice with 1ϫ PBS, and images were captured with fluorescence microscope. eration, also failed to inhibit the increased insulin-stimulated expression of luciferase gene (Fig. 2E) . Generation of reactive nitrogen species, particularly, nitric oxide, was reported as a mediator of HIF-1 activation (33). The nitric oxide had also been reported to attenuate aortic smooth muscle cell motility stimulated by insulin by decreasing H 2 O 2 levels (39). To find out whether nitric oxide has any influence on insulin-stimulated HIF-1 activation initially, we examined nitric oxide generation in insulin-stimulated HepG2 cells. No induced generation of nitric oxide was detected by insulin stimulation (data not shown). Similarly, a specific inhibitor of nitric oxide synthase, N -nitro-L-arginine methyl ester, did not inhibit insulin-mediated HIF-1-DNA complex formation (data not shown), suggesting that nitric oxide has no influence in insulinstimulated HIF-1 activation.
H 2 O 2 reverses DPI-mediated inhibition of HIF-1 activation.
To confirm the role of ROS as well as to identify the oxidant generated by insulin, serum-deprived HepG2 cells were pretreated with 5 M of DPI and, subsequently, H 2 O 2 was added along with insulin. The addition of 30 M H 2 O 2 along with insulin was able to restore the HIF-1 activation even in presence of DPI as detected by EMSA (Fig. 3A) . A similar result was also obtained with transfected HRE-luciferase construct (Fig. 3B) . The role of H 2 O 2 in the HIF-1 activation was further confirmed by greater stimulation of HIF-1 activity, when suboptimal concentration of insulin and H 2 O 2 were added together. Cp-HRE-luciferase construct was transfected in subconfluent HepG2 cells, and the addition of 2 nM insulin was found to increase ϳ1.7-fold luciferase activity. Addition of H 2 O 2 (10 -100 M) with 2 nM of insulin increased the HIF- 1-mediated luciferase activity by Ͼ2 nM insulin treatment (Fig. 3C) , whereas only H 2 O 2 had no effect on HIF-1 activation (data not shown).
Role of NADPH oxidase on the activation of HIF-1 by insulin.
The inhibition of HIF-1 activation by specific inhibitors of NADPH oxidase, DPI and apocynin, strongly indicates the role of NADPH oxidase in this process. To further confirm that, we checked whether the treatment of NADPH compliments the activation of HIF-1 in presence of a suboptimal concentration of insulin. We initially tested the H 2 O 2 generation by NADPH in the presence of a suboptimal concentration of insulin. The generation of H 2 O 2 by 3 nM insulin was ϳ50% less than the maximum generation found by insulin (10 nM). While 25 M NADPH was added along with 3 nM insulin, the generation of H 2 O 2 was found comparable with 10 nM insulinstimulated H 2 O 2 generation (Fig. 4A) . When Cp-HRE-luciferase chimera was transfected into subconfluent HepG2 cells and was treated with either insulin (3 nM) or NADPH (25 M) or both together, the increase in luciferase activity was higher with simultaneous addition of insulin and NADPH compared with insulin alone (Fig. 4B) . The addition of only NADPH did not show any increase in luciferase activity. When NADH (25 M) was added simultaneously with insulin (3 nM), no further induction of luciferase activity, than with only insulin (3 nM), was detected (data not shown). Since DPI also can block mitochondrial NADH oxidase activity, the possibility of participation of NADH oxidase-induced ROS generation was ruled out by this experiment.
It was reported earlier that manganese acts as a cofactor for NADPH-dependent generation of H 2 O 2 in vitro (20) and that supplementation of manganese leads to increased H 2 O 2 generation in the presence of insulin in the isolated plasma membrane of fat cells. To prove further that H 2 O 2 generation by NADPH oxidase plays an essential role in HIF-1 activation, we initially checked whether supplementation of MnCl 2 increases the potentiality of H 2 O 2 generation by insulin in HepG2 cells. We observed that treatment of serum-free HepG2 cells with MnCl 2 before insulin indeed increased insulin-induced H 2 O 2 generation by ϳ60 -70% compared with only insulin treatment (Fig. 4C, inset) . When we repeated the same treatment in Cp-HRE-luciferase chimera transfected HepG2 cells, about 60% increase in luciferase activity in MnCl 2 pretreated cells were detected in presence of insulin (Fig. 4C) . The blocking of increased generation of H 2 O 2 and luciferase activity by DPI confirmed the role of NADPH oxidase.
Insulin-induced H 2 O 2 modulates receptor kinase activity to activate HIF-1. Protein tyrosine phosphatases (PTPases) are known targets for H 2 O 2 generated by insulin and other growth factors by a mechanism that involved oxidation of the catalytic PTPase thiol residue (8) . Inactivation of PTPase leads to activation of receptor-linked protein tyrosine kinases (pY) and subsequent signaling pathways. We hypothesized that blocking of insulin-stimulated H 2 O 2 generation by DPI would keep specific PTPase active so that insulin receptor-linked tyrosine kinases could not be phosphorylated and so that subsequent signaling pathways and target proteins (like HIF-1␣) would not be activated. In that case, treatment with a specific inhibitor of PTPase could reverse the result. To investigate whether insulin-stimulated H 2 O 2 generation is activating HIF-1 by involving similar mechanism, a specific inhibitor of tyrosine phosphatase NaV was added in DPI-treated HepG2 cells to check whether NaV compensates the lack of H 2 O 2 generation and reverses activation of HIF-1. Fig. 5A shows that NaV can restore the DPI-mediated inhibition of HIF-1 activation in the presence of insulin, whereas Ser-Thr phosphatase inhibitor sodium fluoride failed to do so. To further confirm the role of H 2 O 2 as a PTPase blocker, increasing concentrations of NaV were added along with suboptimal concentration of insulin (2 nM), which generates lower levels of H 2 O 2 than the maximal dose of insulin (10 nM). The results showed that treatment of NaV simultaneous with insulin (2 nM) activated HIF-1 more than twofold in a concentration-dependent manner compared with only insulin (2 nM) (Fig. 5B) . To confirm that insulin receptor-linked tyrosine kinases are regulated by ROS, the tyrosine phosphorylation of the insulin receptor and IRS-1/2 were then tested by measuring the insulin-stimulated autophosphorylation of its receptor and its high M r substrate proteins in the HepG2 cells in the presence and absence of DPI or PDTC. Western blot analysis with anti-phosphotyrosine antibody (Fig. 6) revealed that the treatment of the cells with DPI before insulin treatment reduced the tyrosine phosphorylation of IRS and IR-␤ significantly after 5 min of insulin treatment. Similar findings were detected when cells were pretreated with PDTC (100 M) (data not shown). These findings strongly suggest that insulin-stimulated tyrosine phosphorylation receptor and related proteins are regulated by NADPH-linked ROS generation and are also responsible for subsequent activation of HIF-1.
Insulin-induced ROS regulates the PI3-kinase for activation of HIF-1. PI3-kinase was previously reported as a signaling mediator of insulin-induced activation of HIF-1 (36) . To find out whether NADPH oxidase-linked ROS generation regulates PI3-kinase activity and subsequent HIF-1 activation, we initially confirmed the role of PI3-kinase in HIF-1 activation by using specific inhibitor LY-294002. EMSA was performed with Cp-HRE as a HIF-1 binding probe using nuclear extract after insulin treatment from LY-294002-pretreated HepG2 cells. A dose-dependent inhibition of HIF-1-HRE complex formation by the PI3-kinase inhibitor was observed (Fig. 7A) . To find out the influence of insulin-generated oxidant on PI3-kinase activity, the downstream Akt phosphorylation level was tested in the presence and absence of DPI. Exposure of HepG2 to DPI before insulin treatment blocked ϳ80% activation of Akt phosphorylation as found by immunoblotting analysis with phospho-Akt antibody (Fig. 7B) , suggesting the role of oxidant in insulin-stimulated signaling pathways to activate HIF-1.
HIF-1-dependent gene expression by insulin can be blocked by DPI. To finally confirm the influence of NADPH oxidasegenerated ROS in insulin-induced HIF-1-mediated expression of genes, HepG2 cells were treated with DPI before insulin treatment and Northern blot analyses were performed using human VEGF 165 , GLUT1, and Cp gene-specific probes. These genes are known to be regulated by HIF-1 (35, 38) . Figure 8 shows the increase in insulin-induced expressions of VEGF 165 , GLUT1, and Cp mRNA by 2.9-, 3.1-, and 2.3-fold, respectively. The pretreatment of DPI blocked the increased expressions of these genes, confirming the role of NADPH oxidasegenerated ROS in insulin-induced HIF-1-mediated gene expression.
DISCUSSION
Several recent studies confirmed the involvement of mitochondria-generated ROS in hypoxia-induced activation of HIF-1 (5, 6, 11, 26) . In contrast, the participation of ROS in HIF-1 activation by insulin or several other growth factors during normoxia remained unknown. The current study reveals that the activation of HIF-1 by insulin involves NADPH oxidase-linked generation of ROS, particularly, H 2 O 2 . To prove the involvement of ROS in insulin-stimulated activation of HIF-1, the following approaches were taken: 1) inhibition by NADPH oxidase inhibitors DPI, apocynin, as well as ubiquitious antioxidant PDTC; 2) restoration of HIF-1 activation in the presence of NADPH oxidase inhibitor DPI by the addition of external H 2 O 2 ; and 3) maximal activation of HIF-1 by suboptimal concentration of insulin and the addition of H 2 O 2 . In contrast to mitochondrial generation of ROS for HIF-1 activation by hypoxia, we have found the flavoprotein NADPH oxidase-generated ROS is involved in response to insulin. Primarily, we used NADPH oxidase-specific inhibitor DPI and apocynin for blocking HIF-1 activation. Since DPI not only inhibits NADPH oxidase but also blocks mitochondrial NADH oxidase, to rule out the possibility of the participation of the later, we took several biochemical approaches. When the suboptimal concentration of insulin responsible to generate a lower amount of ROS than maximal was supplemented with external NADPH, the increased activation of HIF-1 was found (Fig. 4B) , but an addition of NADH failed to do so. KriegerBrauer and colleagues (20) reported in a series of in vitro biochemical studies that the elaboration of cellular H 2 O 2 during the process of insulin signal transduction is generated by a novel plasma membrane-bound Mn 2ϩ -dependent NADPH oxidase that is coupled to G␣ i2 in adipocytes. Our finding of increased NADPH-dependent H 2 O 2 generation by Mn 2ϩ and insulin in HepG2 cells (Fig. 4C, inset) is consistent with their finding with a purified in vitro system. As a result of increased generation of ROS, the activation of HIF-1 was found to be greater by Mn 2ϩ and insulin cotreatment, providing further evidence of membrane-bound NADPH oxidase-mediated ROS as an essential component for the process (Fig. 4C) . So far it is also not very clear from any studies on how insulin activates NADPH oxidase in living cells, although the specific isoform involved in the process has been identified as NADPH oxidase 4 (Nox-4) in adipocytes, and HepG2 cells were shown to contain a greater amount of Nox-4 than other subunits of NADPH oxidase (27) . The identification of the subunit responsible for ROS generation in response to insulin still remains an open question in HepG2 or H9c2 cells and needs further study.
As a mechanism we found that insulin-induced NADPH oxidase-linked generation of ROS activated insulin receptor tyrosine kinase by apparently inhibiting tyrosine phosphatase. Similar findings were reported previously for insulin in 3T3 adipocytes (24) . In the present work we have demonstrated that the loss of the capacity of H 2 O 2 generation by DPI in insulinstimulated cells can be compensated by the addition of PTPase inhibitor NaV, indicating the role of H 2 O 2 as a transient inhibitor of PTPase. PTPase is known to be inactivated by H 2 O 2 in vivo (3) and thus is a widely known target for insulin-resistance diabetes (16) . This model of insulin-stimulated ROS-mediated inactivation of PTPases and subsequent activation of receptor tyrosine kinases is consistent with other growth factors like EGF-mediated PTPase inactivation (21) . If extrapolated, our result may also explain the mechanism of HIF-1 activation by other growth factors that are capable of ROS generation.
Insulin-stimulated H 2 O 2 generation thus starts a signaling cascade to activate PI3-kinase (Fig. 7A) , which was also reported before to be involved in HIF-1 activation by insulin (36) . Now, in this study, we demonstrated that the insulininduced PI3-kinase is also dependent on NADPH oxidasemediated ROS generation as the downstream phosphorylation of Akt is blocked by DPI and PDTC (Fig. 7B) . The PI3-kinaseAkt pathway has been shown to regulate HIF-1 activity in response to oncogenic signals and growth factors (1, 9), but how phosphorylation of Akt influences HIF-1 activation is not clear so far.
ROS were recognized for several years to have a regulatory role on insulin signal transduction (8) , mainly on the translocation of GLUT4, but were never shown to take part in the process of gene regulation like transcription. Thus our finding of involvement of ROS in insulin-induced HIF-1 activation and subsequent expression of genes indicates that ROS may be crucial for general insulin action in responsive cells. The exposure of cells to exogenous H 2 O 2 has been shown to modulate cellular insulin responsiveness differentially, depending to some extent on the concentration of oxidant, the duration of exposure, and cell type (2, 12) . The exposure of 3T3-L1 adipocytes for several hours to micromolar concentration of H 2 O 2 disrupts insulin-induced subcellular redistribution of IRS-1 and PI3-kinase between the cytosol and the lowdensity microsomal fraction and impairs the insulin-stimulated translocation of GLUT4 (32, 37) , which may explain our observation that the addition of H 2 O 2 alone cannot activate the HIF-1.
Insulin-induced activation of HIF-1 results in the induction of many genes, including VEGF, which plays an important role in developing several pathogenic conditions including angiogenesis and diabetic retinopathy (10, 29, 34) . Since inhibition of increased VEGF expression is one of the probable ways to control these pathogenic situations, our finding of inhibition of VEGF synthesis in response to insulin by antioxidants, particularly those that can block NADPH oxidase activity, may be useful in this regard.
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